Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr 2;285(14):10538-45.
doi: 10.1074/jbc.M109.091116. Epub 2010 Feb 9.

Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression

Affiliations

Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression

Marion Cornu et al. J Biol Chem. .

Abstract

Glucagon-like peptide-1 (GLP-1) protects beta-cells against apoptosis, increases their glucose competence, and induces their proliferation. We previously demonstrated that the anti-apoptotic effect was mediated by an increase in insulin-like growth factor-1 receptor (IGF-1R) expression and signaling, which was dependent on autocrine secretion of insulin-like growth factor 2 (IGF-2). Here, we further investigated how GLP-1 induces IGF-1R expression and whether the IGF-2/IGF-1R autocrine loop is also involved in mediating GLP-1-increase in glucose competence and proliferation. We show that GLP-1 up-regulated IGF-1R expression by a protein kinase A-dependent translational control mechanism, whereas isobutylmethylxanthine, which led to higher intracellular accumulation of cAMP than GLP-1, increased both IGF-1R transcription and translation. We then demonstrated, using MIN6 cells and primary islets, that the glucose competence of these cells was dependent on the level of IGF-1R expression and on IGF-2 secretion. We showed that GLP-1-induced primary beta-cell proliferation was suppressed by Igf-1r gene inactivation and by IGF-2 immunoneutralization or knockdown. Together our data show that regulation of beta-cell number and function by GLP-1 depends on the cAMP/protein kinase A mediated-induction of IGF-1R expression and the increased activity of an IGF-2/IGF-1R autocrine loop.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
GLP-1 increases IGF-1R protein but not mRNA expression in MIN6 cells and primary mouse islets. MIN6 cells were exposed to GLP-1 (100 nm) for the indicated periods of time and IGF-1R mRNA (A) as well as protein (B) expressions were quantitated by qRT-PCR and by Western blot analyses, respectively. Mouse control islets were exposed to GLP-1 (100 nm) for 18 h, and IGF-1R mRNA (C) as well as protein (D) expressions were quantitated by qRT-PCR and by Western blot analyses, respectively. The levels are expressed as arbitrary units (a.u.). The data are the means ± S.D. from three independent experiments. **, p < 0.01; ***, p < 0.001.
FIGURE 2.
FIGURE 2.
IBMX induces a strong increase in both IGF-1R mRNA and protein expression in MIN6 cells and primary mouse islets. MIN6 cells were exposed to IBMX (10 μm) for the indicated periods of time, and IGF-1R mRNA (A) as well as protein (B) expressions were quantitated by qRT-PCR and by Western blot analyses, respectively. Mouse control islets were exposed to IBMX (10 μm) for 18 h and IGF-1R mRNA (C) as well as protein (D) expressions were quantitated by qRT-PCR and by Western blot analyses, respectively. The levels are expressed as arbitrary units (a.u.). The data are the means ± S.D. from three independent experiments. **, p < 0.01; ***, p < 0.001. DMSO, dimethyl sulfoxide; wt, wild type.
FIGURE 3.
FIGURE 3.
GLP-1 and IBMX differentially increase cAMP levels in MIN6 cells. MIN6 cells were incubated in the presence or absence of GLP-1 (100 nm) or IBMX (10 μm) for 30 s or 2 min, and intracellular cAMP contents were measured by radioimmunoassay. The data are the means ± S.D., n = 3 independent experiments. **, p < 0.01 (treatments compared with control); §§, p < 0.01 (IBMX treatment compared with GLP-1 treatment).
FIGURE 4.
FIGURE 4.
IBMX and GLP-1 regulate IGF-1R expression by transcriptional and post-transcriptional mechanisms. A and B, MIN6 cells were exposed to either IBMX (10 μm) or GLP-1 (100 nm) for 18 h and in the presence or absence of actinomycin D (1 μg/ml). IGF1-R mRNA (A) as well as protein (B) expression was quantitated by qRT-PCR and Western blot analysis, respectively. C, MIN6 cells (left panel) or mouse islets (right panel) were biosynthetically labeled for 1 h with [35S]methionine and [35S]cysteine in the presence or absence of GLP-1 (100 nm). IGF-1R was immunoprecipitated from the cell lysates and separated by gel electrophoresis; the amount of newly synthesized precursor receptor was quantitated by densitometric analysis of the autoradiograms. The data are the means ± S.D. from three independent experiments. **, p < 0.01; ***, p < 0.001. Ctrl, control.
FIGURE 5.
FIGURE 5.
GLP-1 and IBMX induce IGF-1R expression through activation of the cAMP/PKA pathway. A, MIN6 cells were exposed for 18 h to GLP-1 (100 nm) to induce IGF-1R expression. This induction was blocked in the presence of the protein kinase A inhibitor H-89 (10 μm) or the cAMP antagonist Rp-CPT-cAMP (100 μm). Activation of Epac2 by 8-CPT-2′-O-Me-cAMP (50 μm) did not induce IGF-1R expression in the absence of GLP-1. B, induction of the IGF-1R by GLP-1 in MIN6 cells expression, which was not suppressed by the MAP kinase inhibitor PD98059 (PD, 50 μm), the PI 3-kinase inhibitors LY294002 (LY, 50 μm), or wortmannin (50 nm) nor by the Ca2+-channel blocker nimodipine (Nimo, 1 μm). C, induction of IGF-1R by IBMX (10 μm) was mimicked by exposing the cells to forskolin (FSK, 10 μm), or the protein kinase A activator SP-CPT-cAMP (100 μm). However, induction of IGF-1R expression was not increased by Epac2 activator 8-CPT-2′-O-Me-cAMP (50 μm) in the absence of IBMX. D, induction of IGF-1R expression by IBMX was not suppressed by PD98059, by LY294002, wortmannin (50 nm), nor by nimodipine. The levels are expressed as arbitrary units (a.u.). The data are the means ± S.D. from three independent experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.001; NS, not significant.
FIGURE 6.
FIGURE 6.
MIN6 glucose competence is modulated by IGF-1R and IGF-2 expression. A, MIN6 cells were co-transfected with a control (pcDNA3) or IGF-1R (pcDNA3-IGF1-R) expression plasmid together with a plasmid encoding hGH. Two days later the cells were exposed to 2 or 20 mm glucose for 1 h, and secreted and intracellular hGH were measured. Secretion was calculated as the ratio of secreted over intracellular hGH, and this ratio was set at 1 for cells treated in control conditions exposed to 2 mm glucose. B, MIN6 cells were co-transfected with an unrelated or an IGF-1R-specific siRNA together with hGH-expressing plasmid. Secretion experiments were performed and expressed as above. C, MIN6 cells were co-transfected with an unrelated or an IGF-2-specific shRNA together with hGH-expressing plasmid. Secretion experiments were performed and expressed as above. The data are the means ± S.D. from three independent experiments. *, p < 0.05; **, p < 0.01.
FIGURE 7.
FIGURE 7.
Mouse islet glucose competence is modulated by IGF-1R and IGF-2 expression. A, mouse islets were infected with a control adenovirus (Ad GFP) or an IGF-1R-expressing adenovirus (AdIGF1-R) and 2 days later exposed to either 2 or 20 mm glucose, and insulin secretion was measured and expressed as in Fig. 6. B, mouse islets were infected as in A and 2 days later exposed to either 2 or 20 mm glucose in the presence of a control IgG or an IGF-2 blocking antibody. Insulin secretion is reported relative to secretion at 2 mm glucose (stimulatory index). C, mouse islets were infected with an adenovirus expressing a unrelated (Luc) or an IGF-2-specific shRNA, and the islets were then processed as above for measurement of glucose-stimulated insulin secretion. The Western blot in the right panel shows the reduction in ProIGF-2 expression in AdshIGF-2-infected cells. IGF-1R, IGF-2, and β-actin expression was detected by Western blot analysis. The data are the means ± S.D. from three independent experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
FIGURE 8.
FIGURE 8.
GLP-1-mediated β-cell proliferation depends on the IGF-2/IGF-1R autocrine loop. A, islets from Igf-1Rlox/lox mice were plated on extracellular matrix-coated dishes for 7 days to form monolayers. They were then infected with Ad-GFP or an Ad-CRE. Two days later they were exposed to GLP-1 (100 nm) for 48 h and then with BrdUrd for the last 24 h. BrdUrd-positive cells were then recorded and are expressed as percentages of BrdUrd-positive cells. B, mouse islets monolayers were exposed to GLP-1 for 48 h in the presence of nonspecific IgG fraction or a neutralizing IGF-2 antibody, and BrdUrd was added for the last 24 h. Proliferation was recorded as BrdUrd-positive cells. C, mouse islet monolayers were infected with an adenovirus expressing an unrelated (Luc) or an IGF-2-specific shRNA. GLP-1-induced proliferation was measured as above. The data are the means ± S.D. from three independent experiments. ***, p < 0.001.

Similar articles

Cited by

References

    1. Egan J. M., Bulotta A., Hui H., Perfetti R. (2003) Diabetes Metab. Res. Rev. 19, 115–123 - PubMed
    1. Drucker D. J. (2006) Cell Metab. 3, 153–165 - PubMed
    1. Thorens B. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 8641–8645 - PMC - PubMed
    1. Gomez E., Pritchard C., Herbert T. P. (2002) J. Biol. Chem. 277, 48146–48151 - PubMed
    1. Arnette D., Gibson T. B., Lawrence M. C., January B., Khoo S., McGlynn K., Vanderbilt C. A., Cobb M. H. (2003) J. Biol. Chem. 278, 32517–32525 - PubMed

Publication types

MeSH terms

LinkOut - more resources